Home > Healthcare > Analytical Instruments > Immunoassay > Immunofluorescence Assay Market

Immunofluorescence Assay Market Share

Report ID: GMI9818
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Immunofluorescence Assay Market Share

The immunofluorescence assay sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Immunofluorescence Assay Market Companies

Some of the eminent market participants operating in the immunofluorescence assay industry include:

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
Danaher Corporation
EpigenTek Group Inc.
MaxVision Biosciences Inc.
Medipan GmbH
Merck & Co., Inc.
J. Mitra & Co. Pvt. Ltd.
Nikon Corporation
Olympus Corporation
PerkinElmer, Inc.
Sino Biological, Inc.
Thermo Fisher Scientific Inc.
Werfen

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of Immunofluorescence assay was reached USD 2.6 billion in 2023 and is estimated to grow at 5.1% CAGR from 2024 to 2032, owing to the increasing prevalence of chronic diseases.

The antibodies segment in the immunofluorescence assay market is predicted to hit USD 1.5 billion by 2032, as infectious diseases necessitate advanced diagnostics.

U.S. immunofluorescence assay market is projected to cross USD 1.5 billion by 2032, attributed to the rising incidence of chronic diseases in the U.S., such as cancer, autoimmune disorders, and infectious diseases.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Danaher Corporation, EpigenTek Group Inc., MaxVision Biosciences Inc., Medipan GmbH, Merck & Co., Inc., J. Mitra & Co. Pvt. Ltd., Nikon Corporation, Olympus Corporation, and PerkinElmer, Inc., among others.